Khosla Ventures is a high-conviction, technology-first firm that backs non-consensus companies capable of reinventing large markets. It invests from Pre-Seed through Growth, but evaluates Seed and Main Fund opportunities differently: at Seed it prioritizes deep technical insight and cheap risk-reduction learning, while at later stages it expects more market proof, GTM clarity, and financial maturity.
Evaluation weights
How much weight this firm places on each dimension. Totals 100%.
Revenue, growth, and unit economics
Size, timing, and competitive landscape
Founder experience and execution ability
Differentiation and technical quality
- Strong bias toward technical insight over polished storytelling
- Prefers bold, non-consensus bets to incremental certainty
- At Seed, prioritizes learning velocity and risk decomposition over spreadsheet precision
- Will tolerate extreme technical risk if the upside and unfair advantage are extraordinary
Pitch difficulty
How hard it is to get a meeting and close funding from this firm.
- Funded / yr
- 139Deals closed in a typical year.
- Led / yr
- 69Rounds led in the last 12 months.
- Pitches / yr
- ~4680Decks reviewed in a typical year.
- Acceptance rate
- 3.0%Share of pitches that get funded.
Estimated — public data is not fully disclosed.
Why it's hard
- Rejects me-too products and incumbent-copying strategies
- Expects precise articulation of technical risks and cheap de-risking milestones
- Targets billion-dollar outcomes with defensible unfair advantages
- Maintains high founder and technical-insight standards across both Seed and Main funds
Khosla Ventures is highly selective because it seeks outlier companies with massive market potential, real technical differentiation, and founders capable of navigating unconventional, high-risk paths. Its willingness to fund very early does not make it easy to access; the bar for originality, technical clarity, and category-defining upside is unusually high.
Green flags
What drives a yes for this firm.
- A bold, technically differentiated idea with a credible path to proving or disproving key assumptions quickly
- Founders with exceptional technical depth, conviction, and the ability to attract outstanding talent
- A very large market where success could produce a category-defining or billion-dollar outcome
- Clear unfair advantage through IP, scientific breakthrough, business-model innovation, or proprietary access
- A practical plan to decompose risk into milestones rather than relying on long-range storytelling
Red flags
What kills deals and gets a fast no.
- Pitching an incremental clone of an existing winner
- Using vanity metrics or long-term financial projections as the primary proof point
- Failing to identify the core technical and market risks explicitly
- Founders who want passive capital rather than active intellectual partnership
- Unclear path to a very large market or no defensible moat if the product works
How to win
Patterns that lead to successful pitches.
- Lead with the non-consensus insight and why now, not with generic market slides
- Show a crisp risk-reduction plan: what are the key unknowns, how will you test them, and what will it cost
- Demonstrate unfair advantage through science, IP, technical architecture, or novel business model
- Present a founder-story that proves exceptional depth, conviction, and recruiting ability
- For later stages, pair the technology thesis with credible GTM, revenue quality, and scaling discipline
Fund strategy & identity
Who they are and how they operate.
- Use Seed fund to back 'crazy ideas' with plausible technical paths before consensus forms
- Use Main fund to scale companies after key technical and market risks are partially retired
- Invest across software, frontier tech, healthcare, fintech, and climate with a bias to disruptive platforms
- Lead aggressively at Seed and selectively follow or co-lead larger rounds later
- Favor startups with unfair advantages rooted in IP, science, novel business models, or unique partnerships
Firm identity
Investment focus
Industries, themes, and typical ARR expectations.
Industries
Investment themes
Typical check by stage
Typical ARR by stage
Investment thesis
Core beliefs and strategy behind their investing approach.
KV’s investment thesis centers on technology‑driven disruption of large, addressable markets. The firm seeks “unfair advantages” such as proprietary IP, breakthrough science, novel business models, or unique partnerships, and prefers founders with deep technical expertise and conviction. Core sectors include Consumer, Enterprise, Fintech, Frontier (space, quantum, deep tech), MedTech & Diagnostics, Digital Health, Therapeutics, and Sustainability/Climate. AI is highlighted as a transformative force across all domains. Geography is global, with a strong U.S. base but investments in India, New Zealand, and other regions. KV targets early‑stage opportunities where a non‑consensus idea can become a category leader, backing both pure science experiments (Seed Fund) and later‑stage scaling (Main Fund). The firm avoids incremental “me‑too” products, business plans that depend on copying incumbents, and pitches that rely solely on long‑term financial projections without concrete technical risk mitigation. Its core belief is that ambitious, technically differentiated startups can reinvent societal goods and generate outsized value, and KV aims to be early, bold, and impactful by backing such “black‑swan” potential.
Decision patterns
How they evaluate and make investment decisions.
KV evaluates investments differently across its Seed and Main funds. For Seed, the firm looks for a “crazy idea” with a plausible technical path and a clear plan to reduce key risks cheaply. Weight is placed on (a) deep technical insight and risk decomposition, (b) founder quality and the ability to “engineer the gene pool,” and (c) a billion‑dollar market opportunity with a defensible unfair advantage (IP, business‑model innovation). They explicitly discount long‑range financial forecasts, vanity user metrics, and me‑too product copies. Deal‑breakers include lack of clear risk‑reduction milestones, teams seeking only capital without willingness to collaborate, and pitches that rely on copying incumbents. For the Main Fund, KV expects more risk to be retired, so market size, financials, go‑to‑market strategy, and team completeness gain weight, though technology risk remains significant. Traction is considered but is secondary at Seed. Overall, team‑tech insight and market potential dominate the decision matrix.
Risk appetite
KV exhibits a high‑conviction, aggressive risk posture. It is willing to lead or be the sole investor in seed rounds, embracing extreme technical uncertainty for ideas that challenge the status quo. The firm describes itself as an “aggressive techno‑optimist,” taking large risks to back “crazy ideas.” While the Main Fund participates in larger rounds (> $10 M) and can co‑lead, KV still prioritizes risk‑elimination learning over perfect financial forecasts. Evidence shows KV frequently leads seed investments (e.g., Redcar, Vertical Oceans, Formulary) and follows in later rounds (e.g., Siphox Health). This blend of lead‑seed aggression with selective follow‑on capacity reflects a willingness to back high‑variance opportunities while providing enough capital to scale once early risks are mitigated.
Notable investments
Key portfolio companies and why they fit the thesis.
- OpendoorReinventing the inefficient real-estate market with a technology-driven operating model. Khosla invested in the 2014 Seed round.
- FormularyLeadAI-based infrastructure for private-market fund administration. Khosla led the $4.6M seed (Jan 2026).
- Peripheral LabsLeadAdvanced sensing and vision tech for autonomous-grade sports experiences. Khosla led the $3.6M seed (Dec 2025).
- Impossible FoodsFood-tech moonshot with massive environmental upside, consistent with KV's sustainability and deep-tech focus.
- Guardant HealthPrecision oncology liquid-biopsy platform that transforms healthcare diagnostics, a classic KV health-tech investment.
- QuantumScapeSolid-state battery technology for EVs, representing KV's deep-tech energy-storage bet.
- NutanixCategory-creating enterprise infrastructure backed pre-revenue, illustrating KV's comfort with high technical risk before metrics appear.
- Ultima GenomicsPlatform that dramatically lowers genomics costs, fitting KV's deep-tech and large-impact healthcare thesis.
Co-invested with
Other firms in this catalog who've backed the same companies.
Partners
Full firm roster — key partners, partners, and the wider team.
Key partners
Vinod Khosla
Founder
Khosla Ventures
Vinod Khosla is the founder of Khosla Ventures and a technologist-investor focused on disruptive, technology-based companies with societal and economic impact.
Samir Kaul
Founding Partner & Managing Director
Khosla Ventures
Samir Kaul is a Founding Partner and Managing Director at Khosla Ventures. His official profile says his interests include AI, advanced technology, health, sustainability and food.
Sven Strohband
Partner and Managing Director
Khosla Ventures
Sven Strohband is a Partner and Managing Director at Khosla Ventures with an engineering background and a focus on technologies that create new industries.
David Weiden
Founding Partner and Managing Director
Khosla Ventures
David Weiden is a Founding Partner and Managing Director at Khosla Ventures focused on internet software and services.
Keith Rabois
Managing Director
Khosla Ventures
Keith Rabois is a Managing Director at Khosla Ventures who invests across sectors and stages. He has more than two decades of founder, operator and investor experience, with public sources associating him with companies including DoorDash, Affirm, Stripe, OpenDoor, PayPal, LinkedIn and Square.
Partners
Julia Purcell
Fund Manager
Khosla Ventures
Fund manager with prior venture fund accounting experience at Carta and Nimble Partners.
Jon Chu
Partner
Khosla Ventures
ML and developer-tools investor; former founder and engineering leader at Palantir, Docker, Opendoor and Facebook.
Brian Byun
Operating Partner
Khosla Ventures
B2B software and cloud infrastructure investor; former VMware product and strategy executive.
Adina Tecklu
Partner
Khosla Ventures
Khosla Ventures partner investing in early-stage software, AI and fintech.
Jai Sajnani
Partner
Khosla Ventures
Growth-stage investor focused on fintech, software and enterprise opportunities.
Saiyed Raza
Khosla Ventures
Semiconductor executive and board member with roles at Arteris, Virsec, Weebit Nano, PeerNova and AMD.
Adrian Nicholas Radu
Partner
Khosla Ventures
Early-stage Khosla partner and former Lightspeed investor across enterprise, fintech and AI.
Rajesh Swaminathan
Partner
Khosla Ventures
Deep-tech investor focused on renewables, decarbonization, manufacturing, critical minerals and AI.
Ethan Choi
Partner
Khosla Ventures
Growth-stage Khosla partner investing across AI, enterprise software and fintech infrastructure.
Alice Brooks
Partner
Khosla Ventures
Deep tech and sustainability investor; former Roominate founder and Nest hardware operator.
Kanu Gulati
Partner
Khosla Ventures
AI infrastructure, robotics and autonomous-systems investor with deep engineering roots.
Katie Mishra
Partner
Khosla Ventures
AI-focused Khosla partner with startup, Meta research and satellite-building experience.
Public voice
Notable statements and public positions.
- “We prefer brutal honesty to hypocritical politeness.” — KV homepage
- “At the seed stage, we’re looking for a crazy idea … We don’t need to see a full team or even complete plans; we need to understand the key technology risks … and the economic and market benefits if it is successful.” — How We Decide page
- “I am a technology possibilist, a techno‑optimist … there is need for regulation but no regulation before its time.” — Vinod Khosla, AI: Dystopia or Utopia blog post
Similar firms
Firms with overlapping stage and industry focus.
Thrive Capital
0.3%
Initialized Capital
3.1%
B Capital
0.2%